One Partner, All Stages: G&H Demonstrates Complete Device Lifecycle Solutions at COMPAMED 2024

With seamless vertical integration, G&H addresses critical challenges in today’s med-tech landscape, such as supply chain resilience, regulatory alignment, and expedited time-to-market. By handling each layer of the device lifecycle through an internal, unified process, G&H eliminates the complexity of multi-vendor dependencies and minimizes risks associated with compliance mismatches and product compatibility issues. This approach brings a considerable advantage to clients, optimizing product quality, delivery timelines, and cost-effectiveness.

The company’s new injection molding capabilities is a powerful addition that has transformed its manufacturing scope since last year, expanding G&H’s capabilities to include the development and production of both instrumentation and disposable or single-use items (consumables). In a market where multiple manufacturers often handle different stages of a single device, G&H’s approach uniquely eliminates fragmentation, ensuring that every component aligns seamlessly within the final product. The company’s success in unifying all stages of manufacturing has translated into substantial improvements for clients, including accelerated time-to-market, enhanced regulatory compliance, and a more consistent user experience.

G&H’s recent expansion of production hubs in both the UK and the US (both of which hold ISO 13485 certifications), as well as key strategic partnerships with low-cost region manufacturers, has also proven invaluable to med-tech clients, fostering closer collaborations and significantly improving customer satisfaction. The synergy between these locations enables G&H to tailor its manufacturing processes to meet the specific regulatory and market needs of each region, allowing for a globally responsive and highly adaptable manufacturing network that spans complexity and volume needs. Through this strategic expansion, G&H can accelerate the development process and enhance design flexibility for medical devices. This addition, alongside its comprehensive in-house development model, bolsters G&H’s promise to provide clients with speed and agility in response to changing demands in life sciences.

“By featuring our enhanced capabilities in injection molding and fully integrated medical device design, G&H is positioning itself as a transformative partner for clients looking to bring innovative biotech solutions to life,” said Bryan Bothwell, Executive Vice President Life Sciences. “Our COMPAMED focus is about making the connection between what’s possible in R&D and what’s achievable in the market in record time – from intricate consumables to the larger diagnostic instruments that drive health outcomes globally.”

Visitors at COMPAMED can find the G&H team at Booth #M24 in Hall 8b to discuss end-to-end development opportunities, including injection molding services tailored to unique project needs. Book a meeting with our experts to learn how G&H’s commitment to innovation can propel your next big biotech breakthrough.